Application 021342

Type
NDA
Sponsor
CEDIPROF INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
002LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
003LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
004LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
005LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
006LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
007LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
008LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
009LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
010LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
011LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo
012LEVO-TLEVOTHYROXINE SODIUMTABLET;ORAL0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 12 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021342-001LEVO-TLEVOTHYROXINE SODIUM0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-002LEVO-TLEVOTHYROXINE SODIUM0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-003LEVO-TLEVOTHYROXINE SODIUM0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-004LEVO-TLEVOTHYROXINE SODIUM0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-005LEVO-TLEVOTHYROXINE SODIUM0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-006LEVO-TLEVOTHYROXINE SODIUM0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-007LEVO-TLEVOTHYROXINE SODIUM0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-008LEVO-TLEVOTHYROXINE SODIUM0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-009LEVO-TLEVOTHYROXINE SODIUM0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-010LEVO-TLEVOTHYROXINE SODIUM0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-011LEVO-TLEVOTHYROXINE SODIUM0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01
N021342-012LEVO-TLEVOTHYROXINE SODIUM0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32003-12-08

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 36 matching rows.

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 13 · 492 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N021342-001LEVO-T0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-002LEVO-T0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-003LEVO-T0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-004LEVO-T0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-005LEVO-T0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-006LEVO-T0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-007LEVO-T0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-008LEVO-T0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-009LEVO-T0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-010LEVO-T0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-011LEVO-T0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-012LEVO-T0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32003-12-08011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021342-001LEVO-T0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021342-002LEVO-T0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021342-003LEVO-T0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021342-004LEVO-T0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021342-005LEVO-T0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021342-006LEVO-T0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021342-007LEVO-T0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021342-008LEVO-T0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021342-009LEVO-T0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021342-010LEVO-T0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021342-011LEVO-T0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-0131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021342-012LEVO-T0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32003-12-0831067a03dcf5…
2025-08-23 18:47 UTC2025-08N021342-001LEVO-T0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-016a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021342-002LEVO-T0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-016a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021342-003LEVO-T0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-016a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021342-004LEVO-T0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-016a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021342-005LEVO-T0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-016a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021342-006LEVO-T0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-016a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021342-007LEVO-T0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-016a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021342-008LEVO-T0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-016a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021342-009LEVO-T0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-016a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021342-010LEVO-T0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-016a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021342-011LEVO-T0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-016a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021342-012LEVO-T0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32003-12-086a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021342-001LEVO-T0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021342-002LEVO-T0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021342-003LEVO-T0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021342-004LEVO-T0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB32002-03-01fd3edfee7708…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 37 · 1,476 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02N021342-001AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-001AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-001AB33011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-002AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-002AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-002AB33011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-003AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-003AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-003AB33011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-004AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-004AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-004AB33011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-005AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-005AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-005AB33011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-006AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-006AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-006AB33011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-007AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-007AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-007AB33011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-008AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-008AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-008AB33011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-009AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-009AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-009AB33011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-010AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-010AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-010AB33011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-011AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-011AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-011AB33011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-012AB11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-012AB22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021342-012AB33011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021342-001AB1131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021342-001AB2231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021342-001AB3331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021342-002AB1131067a03dcf5…

Observed Orange Book patent history#

Patent history page 1 of 2 · 66 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2019-12-13 00:20 UTC2019-12N021342-00163991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-00263991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-00363991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-00463991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-00563991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-00663991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-00763991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-00863991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-00963991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-01063991012020-03-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021342-01163991012020-03-3074a2ff9319b5…
2020-12-22 03:56 UTC2020-12N021342-00163991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-00263991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-00363991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-00463991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-00563991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-00663991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-00763991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-00863991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-00963991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-01063991012020-03-308869cabd3fbd…
2020-12-22 03:56 UTC2020-12N021342-01163991012020-03-308869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021342-00163991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-00263991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-00363991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-00463991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-00563991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-00663991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-00763991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-00863991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-00963991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-01063991012020-03-30c0c555d07b60…
2020-11-12 02:37 UTC2020-11N021342-01163991012020-03-30c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021342-00163991012020-03-303f01610625f2…
2019-12-14 00:12 UTC2019-12N021342-00263991012020-03-303f01610625f2…
2019-12-14 00:12 UTC2019-12N021342-00363991012020-03-303f01610625f2…
2019-12-14 00:12 UTC2019-12N021342-00463991012020-03-303f01610625f2…
2019-12-14 00:12 UTC2019-12N021342-00563991012020-03-303f01610625f2…
2019-12-14 00:12 UTC2019-12N021342-00663991012020-03-303f01610625f2…
2019-12-14 00:12 UTC2019-12N021342-00763991012020-03-303f01610625f2…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 3 · 48 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack489ffba8-983e-478f-8f62-fe08bf3d0e0b2026-06-23Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack5852d874-1ebc-49ff-b6c2-1dd513fca7842026-05-27Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepackdb5cba81-9ad5-42ad-ac9e-a967337630f22026-05-22Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepackd9ccea69-109d-44cf-927b-4ff67652b6a02026-05-22Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack50978a14-fd72-4c76-927f-667a1f097b872026-05-21Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepacke293dd94-b523-47a2-8bed-e6d99945ee592026-05-15Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack776c8dbc-ca34-40f9-9730-4aa59f6447032026-05-15Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack5c1cf991-6177-499d-a9b8-63e5ca92eb792026-05-15Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack3142571d-f253-45e7-adc1-6ca80d34cab12026-05-15Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack513d066a-2fcc-44ad-80e1-23c339a56ac62026-05-15Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack1aaa327d-bb10-4815-8bd3-d8c9edc6c9db2026-05-14Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack64a663ac-ac02-4325-8f21-ee212e5461212026-05-14Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack4caf9040-5507-45a4-8f42-231aa925ab8d2026-04-16Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack0210a600-747e-433a-8ba9-11692ecfb54a2026-04-07Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepackef7bc627-d37b-470e-b8f7-3c472c930d052026-04-07Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepackd0beda93-9454-4846-b5c6-2a9113fb17652026-04-07Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack0b9d21d8-9b49-4fd2-b516-b25bc6a6b6712026-04-07Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepackcaf7825d-f434-472f-94f3-217a412555622026-04-07Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack73c3d459-dcbf-4458-8edd-2637275a96a12026-03-31Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342
Levothyroxine SodiumLEVOTHYROXINE SODIUMBryant Ranch Prepack4461bc9f-35db-4211-82ab-7671cf4dc14b2026-03-27Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021342
application number: NDA021342

NDC Listings For This Application#

NDC listings for this application page 2 of 5 · 350 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
51655-295Levothyroxine SodiumLevothyroxine SodiumNorthwind PharmaceuticalsNDACurrent
51655-299LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMNorthwind Pharmaceuticals, LLCNDACurrent
51655-749Levothyroxine SodiumLevothyroxine SodiumNorthwind Pharmaceuticals, LLCNDACurrent
53808-1115Levothyroxine sodiumLevothyroxine sodiumDOH CENTRAL PHARMACYNDA AUTHORIZED GENERICCurrent
55466-104LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-104LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-104LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-104LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-105LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-105LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-105LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-105LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-106LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-106LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-106LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-106LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-107LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-107LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-107LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-107LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-108LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-108LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-108LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-108LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-109LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-109LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-109LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-109LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-110LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-110LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-110LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-110LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-111LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-111LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-111LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-111LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-112LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-112LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-112LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-112LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-113LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-113LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-113LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-113LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-114LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-114LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-114LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-114LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-115LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-115LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-115LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
55466-115LEVO-TLevothyroxine SodiumNeolpharma, Inc.NDACurrent
61919-197Levothroxine SodiumLevothroxine SodiumDirect_RxNDA AUTHORIZED GENERICCurrent
61919-466LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDACurrent
61919-466LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDACurrent
61919-549LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDACurrent
61919-549LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDACurrent
61919-810LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDACurrent
61919-810LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDA AUTHORIZED GENERICCurrent
61919-816LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDACurrent
61919-816LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDA AUTHORIZED GENERICCurrent
61919-870LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDA AUTHORIZED GENERICCurrent
61919-870LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDA AUTHORIZED GENERICCurrent
61919-872LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirectRxNDA AUTHORIZED GENERICCurrent
61919-872LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMDirect_RxNDA AUTHORIZED GENERICCurrent
63187-851Levothyroxine sodiumLevothyroxine sodiumProficient Rx LPNDA AUTHORIZED GENERICCurrent
63187-851Levothyroxine sodiumLevothyroxine sodiumProficient Rx LPNDA AUTHORIZED GENERICCurrent
63187-924Levothyroxine sodiumLevothyroxine sodiumProficient Rx LPNDA AUTHORIZED GENERICCurrent
63187-924Levothyroxine sodiumLevothyroxine sodiumProficient Rx LPNDA AUTHORIZED GENERICCurrent
63187-924Levothyroxine sodiumLevothyroxine sodiumProficient Rx LPNDA AUTHORIZED GENERICCurrent
63187-982Levothyroxine sodiumLevothyroxine sodiumProficient Rx LPNDA AUTHORIZED GENERICCurrent
63187-982Levothyroxine sodiumLevothyroxine sodiumProficient Rx LPNDA AUTHORIZED GENERICCurrent
63629-1837Levothyroxine sodiumLevothyroxine sodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent
63629-1837Levothyroxine sodiumLevothyroxine sodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent
63629-1837Levothyroxine sodiumLevothyroxine sodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent
63629-2088Levothyroxine SodiumLevothyroxine SodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent
63629-2088Levothyroxine SodiumLevothyroxine SodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent
63629-2089Levothyroxine SodiumLevothyroxine SodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent
63629-2089Levothyroxine SodiumLevothyroxine SodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent
63629-2090Levothyroxine SodiumLevothyroxine SodiumBryant Ranch PrepackNDA AUTHORIZED GENERICCurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85838SUPPL 2026-05-21
85864SUPPL 2026-05-11
50625SUPPL2017-12-07
50624SUPPL2017-12-07
27524SUPPL2011-03-11
15222SUPPL2009-06-22
27523SUPPL2009-06-17
27522SUPPL2008-06-13
27521SUPPL2008-06-13
36694SUPPL2008-06-12
15221SUPPL2008-06-12
42112SUPPL2005-05-13
42111SUPPL2005-05-13
5088SUPPL2004-06-24
5087SUPPL2004-06-24
36692SUPPL2003-12-11
5085SUPPL2003-12-11
36693SUPPL2003-08-28
5086SUPPL2003-08-28
69369ORIG2002-06-19
21609ORIG2002-06-19
27520ORIG2002-03-01
15220ORIG2002-03-01